Which hedge funds own INGN? INOGEN INC, Q2 2026 13F holders
HealthcareMedical DevicesFollow
18 tracked hedge funds disclosed a position in INGN (INOGEN INC) in their Q2 2026 13F filings, worth $35.1m in total. The largest holder by portfolio weight is PharVision Advisers, LLC at 1.6% of its book. 3 opened a new position this quarter: PharVision Advisers, LLC, Readystate Asset Management LP, Jain Global LLC. 6 exited: Tudor Investment Corp ET AL, Centiva Capital, LP, Trexquant Investment LP.
18
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
3
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
6
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$1.9m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$4.7m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$35.1m
Combined value
Sum of the holders' reported positions in the security.
1.5%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.